Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Transplant Is Horrendous in the Beginning — You’re Not Abnormal Immunotherapy May Be Promising Strategy to Treat Chronic Infections of P. aeruginosa in CF Patients Transplant Is Horrendous in the Beginning — You’re Not Abnormal Jan 15, 2019 09:00 am | Brad Dell On the night of Jan. 15, 2016, nurses rolled me in for surgery. I rolled out on Jan. 16 with a donor’s lungs. It’s been two years packed with awe. I love my post-transplant life. I’ve traveled all over, picked up new passions, and my addiction to life only grows. It all didn’t start smooth. […] The post Transplant Is Horrendous in the Beginning — You’re Not Abnormal appeared first on Cystic Fibrosis News Today. Read More Immunotherapy May Be Promising Strategy to Treat Chronic Infections of P. aeruginosa in CF Patients Jan 15, 2019 07:00 am | Marta Figueiredo Blocking the interaction between two molecules involved in immune restraining mechanisms — called PD-1 and PD-L1 — may be an effective therapeutic strategy to boost the immune system and treat chronic infections of Pseudomonas aeruginosa in cystic fibrosis (CF) patients, according to a recent study. The study, “Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing […] The post Immunotherapy May Be Promising Strategy to Treat Chronic Infections of P. aeruginosa in CF Patients appeared first on Cystic Fibrosis News Today. Read More   Recent News Let’s Use the Cystic Fibrosis News Today Forums for Empowerment Eluforsen Improves CFTR Protein Function in CF Patients with F508del Mutations, Phase 1 Trial Shows WHO Approves Ensifentrine as Name for Potential Inhaled Treatment Now in Clinical Trials New Inhaled Carrier May Work for CF mRNA Therapy, Mouse Study Finds Alcresta’s Relizorb Given Medicare/Medicaid Billing Code for Easier Claims